Remedy Entertainment Oyj (REMEDY) Earnings Call Transcripts
Remedy Entertainment Oyj's Latest Earnings Call - Q1 FY2026
In Q1 2026, Remedy Entertainment Oyj reported revenues of EUR 13.1 million, a 2% decline year-over-year, primarily due to a decrease in development fees, although game sales and royalties nearly doubled to EUR 5 million. EBITDA improved to EUR 2.9 million, while EBIT was positive at EUR 1 million, indicating a profitable quarter ahead of the launch of CONTROL Resonant. Management maintained its full-year guidance, expecting revenue and EBITDA to increase compared to the previous year, signaling confidence in upcoming game releases and marketing efforts.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | EUR 13.1 million (miss) |
| EBITDA | EUR 2.9 million (beat) |
| EBIT | EUR 1.0 million (miss) |
| Game Sales and Royalties | EUR 5 million (beat) |
| Cash Position | EUR 34 million (positive) |
| Operating Cash Flow | EUR 8.3 million (beat) |
Guidance from management
Management maintained its full-year guidance, expecting revenue and EBITDA to increase from the previous year, indicating confidence in upcoming game releases and marketing efforts.
What management said
Ladies and gentlemen, welcome to the webcast for Remedy's Q1 Business Review of 2026. My name is Aapo Kilpinen from Remedy's Investor Relations. Joining with me today are Remedy's new CEO, Jean-Charles Gaudechon, also known as JC; and then our CFO, Santtu Kallionpaa. JC will briefly introduce himself and then guide us to the quarter. Santtu will then do a deeper dive on the financials of the quarter. We'll then look ...
Thank you, Santtu. All right. Our outlook for 2026 is unchanged. We expect our full year revenue and EBITDA to increase from the previous year. And then handing it to Aapo for Q&A.
What analysts pressed on
Analysts expressed concerns regarding the impact of development fee trends on future revenue stability and the potential risks associated with entering the action RPG genre with CONTROL Resonant. Additionally, there were questions about the effectiveness of the localization strategy in new markets.
Main topics on the call
- Revenue Dynamics — Q1 2026 revenue was EUR 13.1 million, down 2% YoY, with game sales and royalties nearly doubling to EUR 5 million, driven by Alan Wake 2 royalties. Management noted, "The share of game sales and royalties of the total re...
- Profitability Metrics — EBITDA for Q1 2026 was EUR 2.9 million, an improvement from the previous year, while EBIT was positive at EUR 1 million. Management stated, "This is, of course, ahead of marketing ramp-up and related spend to support the...
- CONTROL Resonant Launch — Management emphasized the importance of the upcoming CONTROL Resonant, stating, "Today, it's really to give the studio the support, the direction, the inspiration to really kind of get CONTROL Resonant across the finish ...
- Market Expansion Strategy — Remedy is focusing on expanding its market presence in Asia and Latin America, with significant localization investments. CEO Gaudechon mentioned, "This time around, Asia and Latin America are real priorities for this la...
Read the full Remedy Entertainment Oyj transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Remedy Entertainment Oyj
Remedy Entertainment Oyj (REMEDY) is a publicly listed company in the Entertainment industry, within the Communication Services sector. It trades on HLSE and is based in FI. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 25 calls on record spanning August 14, 2020 to August 11, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 25 Remedy Entertainment Oyj earnings call transcripts on record, spanning August 14, 2020 to August 11, 2026. Based on this history, Remedy Entertainment Oyj reports quarterly. The most recent call on file is dated August 11, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- REMEDY
- Exchange
- HLSE
- Country
- FI
- Sector
- Communication Services
- Industry
- Entertainment
- Calls on record
- 25
- First call
- August 14, 2020
- Most recent
- August 11, 2026
- Reporting cadence
- quarterly